Enhanced Signaling and Morphological Transformation by a Membrane-Localized Derivative of the Fibroblast Growth Factor Receptor 3 Kinase Domain†

REFERENCES

• Adnane, J., P. Gaudray, C. A. Dionne, G. Crumley, M. Jaye, J. Schlessinger, P. Jeanteur, D. Birnbaum, and C. Theillet. 1991. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6:659–663.
   PubMed Web of Science ®Google Scholar
• Aronheim, A., D. Engelberg, N. Li, N. al-Alawi, J. Schlessinger, and M. Karin. 1994. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78:949–961.
   PubMed Web of Science ®Google Scholar
• Bargmann, C. I., M. C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649–657.
   PubMed Web of Science ®Google Scholar
• Basilico, C., and D. Moscatelli. 1992. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59:115–165.
   PubMed Web of Science ®Google Scholar
• Bongarzone, I., N. Monzini, M. G. Borrello, C. Carcano, G. Ferraresi, E. Arighi, P. Mondellini, G. Della Porta, and M. A. Pierotti. 1993. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol. Cell. Biol. 13:358–366.
   PubMed Web of Science ®Google Scholar
• Buss, J. E., C. J. Der, and P. A. Solski. 1988. The six amino-terminal amino acids of p60src are sufficient to cause myristylation of p21v-ras. Mol. Cell. Biol. 8:3960–3963.
   PubMedGoogle Scholar
• Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
   PubMed Web of Science ®Google Scholar
• Chesi, M., E. Nardini, L. A. Brents, E. Schrock, T. Ried, W. M. Kuehl, and P. L. Bergsagel. 1997. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma: association with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genet., 16:260–264.
   PubMed Web of Science ®Google Scholar
• Curtis, B. M., M. B. Widmer, P. deRoos, and E. E. Qwarnstrom. 1990. IL-1 and its receptor are translocated to the nucleus. J. Immunol. 144:1295–1303.
   PubMed Web of Science ®Google Scholar
• Delli Bovi, P., A. M. Curatola, F. G. Kern, A. Greco, M. Ittmann, and C. Basilico. 1987. An oncogene isolated by transfection of Kaposi’s sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50:729–737.
   PubMed Web of Science ®Google Scholar
• Friesel, R. E., and T. Maciag. 1995. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9:919–925.
   PubMed Web of Science ®Google Scholar
• Goldfarb, M., R. Deed, D. MacAllan, W. Walther, C. Dickson, and G. Peters. 1991. Cell transformation by Int-2—a member of the fibroblast growth factor family. Oncogene 6:65–71.
   PubMed Web of Science ®Google Scholar
• Golub, T. R., G. F. Barker, M. Lovett, and D. G. Gilliland. 1994. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307–316.
   PubMed Web of Science ®Google Scholar
• Hattori, Y., H. Odagiri, H. Nakatani, K. Miyagawa, K. Naito, H. Sakamoto, O. Katoh, T. Yoshida, T. Sugimura, and M. Terada. 1990. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc. Natl. Acad. Sci. USA 87:5983–5987.
   PubMed Web of Science ®Google Scholar
• Hayman, M. J., and P. J. Enrietto. 1991. Cell transformation by the epidermal growth factor receptor and v-erbB. Cancer Cells 3:302–307.
   PubMed Web of Science ®Google Scholar
• Horlick, R. A., S. L. Stack, and G. M. Cooke. 1992. Cloning, expression and tissue distribution of the gene encoding rat fibroblast growth factor receptor subtype 4. Gene 120:291–295.
   PubMedGoogle Scholar
• Hou, J. Z., M. K. Kan, K. McKeehan, G. McBride, P. Adams, and W. L. McKeehan. 1991. Fibroblast growth factor receptors from liver vary in three structural domains. Science 251:665–668.
   PubMedGoogle Scholar
• Hu, Q., D. Milfay, and L. T. Williams. 1995. Binding of NCK to SOS and activation of ras-dependent gene expression. Mol. Cell. Biol. 15:1169–1174.
   PubMed Web of Science ®Google Scholar
• Imamura, T., K. Engleka, X. Zhan, Y. Tokita, R. Forough, D. Roeder, A. Jackson, J. A. Maier, T. Hla, and T. Maciag. 1990. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 249:1567–1570.
   PubMed Web of Science ®Google Scholar
• Jans, D. A. 1994. Nuclear signaling pathways for polypeptide ligands and their membrane receptors? FASEB J. 8:841–847.
   PubMed Web of Science ®Google Scholar
• Jaye, M., J. Schlessinger, and C. A. Dionne. 1992. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta 1135:185–199.
   PubMed Web of Science ®Google Scholar
• Jiang, L. W., and M. Schindler. 1990. Nucleocytoplasmic transport is enhanced concomitant with nuclear accumulation of epidermal growth factor (EGF) binding activity in both 3T3-1 and EGF receptor reconstituted NR-6 fibroblasts. J. Cell Biol. 110:559–568.
   PubMed Web of Science ®Google Scholar
• Johnson, D. E., and L. T. Williams. 1993. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60:1–41.
   PubMed Web of Science ®Google Scholar
• Johnston, C. L., H. C. Cox, J. J. Gomm, and R. C. Coombes. 1995. Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J. Biol. Chem. 270:30643–30650.
   PubMed Web of Science ®Google Scholar
• Kamps, M. P., J. E. Buss, and B. M. Sefton. 1985. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proc. Natl. Acad. Sci. USA 82:4625–4628.
   PubMed Web of Science ®Google Scholar
• Kan, M., F. Wang, B. To, J. L. Gabriel, and W. L. McKeehan. 1996. Divalent cations and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex. J. Biol. Chem. 271:26143–26148.
   PubMed Web of Science ®Google Scholar
• Kanai, M., M. Goke, S. Tsunekawa, and D. K. Podolsky. 1997. Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein. J. Biol. Chem. 272:6621–6628.
   PubMed Web of Science ®Google Scholar
• Kobrin, M. S., Y. Yamanaka, H. Friess, M. E. Lopez, and M. Korc. 1993. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res. 53:4741–4744.
   PubMedGoogle Scholar
• Kouhara, H., S. Kurebayashi, K. Hashimoto, S. Kasayama, M. Koga, T. Kishimoto, and B. Sato. 1995. Ligand-independent activation of tyrosine kinase in fibroblast growth factor receptor 1 by fusion with beta-galactosidase. Oncogene 10:2315–2322.
   PubMedGoogle Scholar
• Leevers, S. J., H. F. Paterson, and C. J. Marshall. 1994. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369:411–414.
   PubMed Web of Science ®Google Scholar
• Lobie, P. E., T. J. Wood, C. M. Chen, M. J. Waters, and G. Norstedt. 1994. Nuclear translocation and anchorage of the growth hormone receptor. J. Biol. Chem. 269:31735–31746.
   PubMed Web of Science ®Google Scholar
• Lorenzi, M. V., Y. Horii, R. Yamanaka, K. Sakaguchi, and T. Miki. 1996. Frag1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement. Proc. Natl. Acad. Sci. USA 93:8956–8961.
   PubMedGoogle Scholar
• MacArthur, C. A., A. Lawshe, D. B. Shankar, M. Heikinheimo, and G. M. Shackleford. 1995. FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Differ. 6:817–825.
   PubMedGoogle Scholar
• Maher, P. A. 1996. Identification and characterization of a novel, intracellular isoform of fibroblast growth factor receptor-1 (Fgfr-1). J. Cell. Physiol. 169:380–390.
   PubMed Web of Science ®Google Scholar
• Maher, P. A. 1996. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 134:529–536.
   PubMedGoogle Scholar
• Marics, I., J. Adelaide, F. Raybaud, M. G. Mattei, F. Coulier, J. Planche, O. de Lapeyriere, and D. Birnbaum. 1989. Characterization of the HST- related FGF6 gene, a new member of the fibroblast growth factor gene family. Oncogene 4:335–340.
   PubMed Web of Science ®Google Scholar
• Mohammadi, M., J. Schlessinger, and S. R. Hubbard. 1996. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86:577–587.
   PubMed Web of Science ®Google Scholar
• Muenke, M., and U. Schell. 1995. Fibroblast-growth-factor receptor mutation in human skeletal disorders. Trends Genet. 11:308–313.
   PubMed Web of Science ®Google Scholar
• Nakamoto, T., C. S. Chang, A. K. Li, and G. W. Chodak. 1992. Basic fibroblast growth factor in human prostate cancer cells. Cancer Res. 52:571–577.
   PubMed Web of Science ®Google Scholar
• Park, W. J., G. A. Bellus, and E. W. Jabs. 1995. Mutations in fibroblast growth factor receptors: phenotypic consequences during eukaryotic development. Am. J. Hum. Genet. 57:748–754.
   PubMedGoogle Scholar
• Peters, K., D. Ornitz, S. Werner, and L. Williams. 1993. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155:423–430.
   PubMed Web of Science ®Google Scholar
• Podlecki, D. A., R. M. Smith, M. Kao, P. Tsai, T. Huecksteadt, D. Brandenburg, R. S. Lasher, L. Jarett, and J. M. Olefsky. 1987. Nuclear translocation of the insulin receptor. A possible mediator of insulin’s long term effects. J. Biol. Chem. 262:3362–3368.
   PubMed Web of Science ®Google Scholar
• Prudovsky, I., N. Savion, X. Zhan, R. Friesel, J. Xu, J. Hou, W. L. McKeehan, and T. Maciag. 1994. Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1. J. Biol. Chem. 269:31720–31724.
   PubMedGoogle Scholar
• Prudovsky, I. A., N. Savion, T. M. LaVallee, and T. Maciag. 1996. The nuclear trafficking of extracellular fibroblast growth factor (FGF)-1 correlates with the perinuclear association of the FGF receptor-1alpha isoforms but not the FGF receptor-1beta isoforms. J. Biol. Chem. 271:14198–14205.
   PubMed Web of Science ®Google Scholar
• Robbins, J., S. M. Dilworth, R. A. Laskey, and C. Dingwall. 1991. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64:615–623.
   PubMed Web of Science ®Google Scholar
• Rodrigues, G. A., and M. Park. 1993. Dimerization mediated through a leucine zipper activates the oncogenic potential of the Met receptor tyrosine kinase. Mol. Cell. Biol. 13:6711–6722.
   PubMedGoogle Scholar
• Rousseau, F., V. el Ghouzzi, A. L. Delezoide, L. Legeai-Mallet, M. Le Merrer, A. Munnich, and J. Bonaventure. 1996. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TDI). Hum. Mol. Genet. 5:509–512.
   PubMedGoogle Scholar
• Sawyers, C. L., and C. T. Denny. 1994. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about. Cell 77:171–173.
   PubMed Web of Science ®Google Scholar
• Shu, H. K., R. J. Pelley, and H. J. Kung. 1990. Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential. Proc. Natl. Acad. Sci. USA 87:9103–9107.
   PubMed Web of Science ®Google Scholar
• Spivak-Kroizman, T., M. A. Lemmon, I. Dikic, J. E. Ladbury, D. Pinchasi, J. Huang, M. Jaye, G. Crumley, J. Schlessinger, and I. Lax. 1994. Heparin- induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79:1015–1024.
   PubMed Web of Science ®Google Scholar
• Su, W. C., M. Kitagawa, N. Xue, B. Xie, S. Garofalo, J. Cho, C. Deng, W. A. Horton, and X. Y. Fu. 1997. Activation of Stat1 by mutant fibroblast growth- factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386:288–292.
   PubMed Web of Science ®Google Scholar
• Takahashi, J. A., H. Mori, M. Fukumoto, K. Igarashi, M. Jaye, Y. Oda, H. Kikuchi, and M. Hatanaka. 1990. Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc. Natl. Acad. Sci. USA 87:5710–5714.
   PubMed Web of Science ®Google Scholar
• Tavormina, P. L., R. Shiang, L. M. Thompson, Y. Z. Zhu, D. J. Wilkin, R. S. Lachman, W. R. Wilcox, D. L. Rimoin, D. H. Cohn, and J. J. Wasmuth. 1995. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9:321–328.
   PubMed Web of Science ®Google Scholar
• Tavormina, P. L., G. A. Bellus, M. K. Webster, M. J. Bamshad, A. E. Fraley, I. McIntosh, J. Szabo, W. Jiang, E. W. Jabs, W. R. Wilcox, J. J. Wasmuth, D. J. Donoghue, L. M. Thompson, and C. A. Francomano. Thanatophoric dysplasia type II and a unique skeletal dysplasia with acanthosis nigricans and mental retardation are caused by two different point mutations within codon 650 of the fibroblast growth factor receptor 3 (FGFR3) gene. Submitted for publication.
   Google Scholar
• Theillet, C., X. Le Roy, O. De Lapeyriere, J. Grosgeorges, J. Adnane, S. D. Raynaud, J. Simony-Lafontaine, M. Goldfarb, C. Escot, and D. Birnbaum. 1989. Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. Oncogene 4:915–922.
   PubMed Web of Science ®Google Scholar
• Webster, M. K., P. Y. D’Avis, S. C. Robertson, and D. J. Donoghue. 1996. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol. 16:4081–4087.
   PubMed Web of Science ®Google Scholar
• Webster, M. K., and D. J. Donoghue. 1996. Constitutive activation of fibro- blast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15:520–527.
   PubMed Web of Science ®Google Scholar
• Webster, M. K., and D. J. Donoghue. 1997. FGFR activation in skeletal disorders: too much of a good thing. Trends Genet. 13:178–182.
   PubMed Web of Science ®Google Scholar
• Wiedlocha, A., P. O. Falnes, I. H. Madshus, K. Sandvig, and S. Olsnes. 1994. Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell 76:1039–1051.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, F., H. Saya, J. M. Bruner, and R. S. Morrison. 1994. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl. Acad. Sci. USA 91:484–488.
   PubMed Web of Science ®Google Scholar
• Yamanaka, Y., H. Friess, M. Buchler, H. G. Beger, E. Uchida, M. Onda, M. S. Kobrin, and M. Korc. 1993. Overexpression of acidic and basic fibro- blast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res. 53:5289–5296.
   PubMed Web of Science ®Google Scholar
• Yan, G., Y. Fukabori, G. McBride, S. Nikolaropolous, and W. L. McKeehan. 1993. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol. 13:4513–4522.
   PubMed Web of Science ®Google Scholar
• Zhan, X., X. Hu, R. Friesel, and T. Maciag. 1993. Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells. J. Biol. Chem. 268:9611–9620.
   PubMed Web of Science ®Google Scholar
• Zhan, X., B. Bates, X. G. Hu, and M. Goldfarb. 1988. The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol. Cell. Biol. 8:3487–3495.
   PubMed Web of Science ®Google Scholar